NICE to consult on delayed ‘value-based’ drug pricing plans

Hand with pills

The National Institute for Health and Care Excellence is to announce proposals on Thursday that could see the health service increase the amount it spends on branded pharmaceutical drugs.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here